{"id":"https://openalex.org/W4362548233","doi":"https://doi.org/10.1158/2326-6066.c.6551043","title":"Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors","display_name":"Data from Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors","publication_year":2023,"publication_date":"2023-04-04","ids":{"openalex":"https://openalex.org/W4362548233","doi":"https://doi.org/10.1158/2326-6066.c.6551043"},"language":"en","primary_location":{"id":"doi:10.1158/2326-6066.c.6551043","doi":"https://doi.org/10.1158/2326-6066.c.6551043","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6551043","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/2326-6066.c.6551043","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5076370806","display_name":"Jeroen Slaats","orcid":"https://orcid.org/0000-0003-3800-3138","observed_orcids":["https://orcid.org/0000-0003-3800-3138"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jeroen Slaats","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3800-3138","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077005500","display_name":"Esther Wagena","orcid":"https://orcid.org/0000-0002-6722-1495","observed_orcids":["https://orcid.org/0000-0002-6722-1495"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Esther Wagena","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6722-1495","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083969796","display_name":"Daan Smits","orcid":"https://orcid.org/0000-0002-3090-4321","observed_orcids":["https://orcid.org/0000-0002-3090-4321"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Daan Smits","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3090-4321","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006146706","display_name":"Annemarie A. Berends","orcid":"https://orcid.org/0000-0001-5124-8821","observed_orcids":["https://orcid.org/0000-0001-5124-8821"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Annemarie A. Berends","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-5124-8821","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031426836","display_name":"Ella Peters","orcid":"https://orcid.org/0000-0002-3622-8475","observed_orcids":["https://orcid.org/0000-0002-3622-8475"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ella Peters","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-3622-8475","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082642221","display_name":"Gert\u2010Jan Bakker","orcid":"https://orcid.org/0000-0003-3602-0014","observed_orcids":["https://orcid.org/0000-0003-3602-0014"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gert-Jan Bakker","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-3602-0014","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067213239","display_name":"Merijn van Erp","orcid":"https://orcid.org/0000-0002-9642-9789","observed_orcids":["https://orcid.org/0000-0002-9642-9789"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Merijn van Erp","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-9642-9789","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019346530","display_name":"Bettina Weigelin","orcid":"https://orcid.org/0000-0003-4460-3113","observed_orcids":["https://orcid.org/0000-0003-4460-3113"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bettina Weigelin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0003-4460-3113","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015323424","display_name":"Gosse J. Adema","orcid":"https://orcid.org/0000-0002-6750-1665","observed_orcids":["https://orcid.org/0000-0002-6750-1665"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gosse J. Adema","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-6750-1665","affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5026527299","display_name":"Peter Friedl","orcid":"https://orcid.org/0000-0002-0119-4041","observed_orcids":["https://orcid.org/0000-0002-0119-4041"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Peter Friedl","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0119-4041","affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.009399999864399433,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0017999999690800905,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.972000002861023},{"id":"https://openalex.org/keywords/cytotoxic-t-lymphocytes","display_name":"cytotoxic T lymphocytes","score":0.9800000190734863},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.7770000100135803},{"id":"https://openalex.org/keywords/extracellular-adenosine","display_name":"extracellular adenosine","score":0.906000018119812},{"id":"https://openalex.org/keywords/tumor-microenvironment-metabolism","display_name":"tumor microenvironment metabolism","score":0.7369999885559082},{"id":"https://openalex.org/keywords/immunosuppression","display_name":"immunosuppression","score":0.6869999766349792},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.8050000071525574}],"concepts":[{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.8366608023643494},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.6784653067588806},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.5856173038482666},{"id":"https://openalex.org/C51785407","wikidata":"https://www.wikidata.org/wiki/Q2627568","display_name":"Effector","level":2,"score":0.5389377474784851},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.529447078704834},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.518369734287262},{"id":"https://openalex.org/C67907053","wikidata":"https://www.wikidata.org/wiki/Q356147","display_name":"Adenosine receptor","level":4,"score":0.49094775319099426},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.43905529379844666},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.43690991401672363},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.4282303750514984},{"id":"https://openalex.org/C2776107976","wikidata":"https://www.wikidata.org/wiki/Q1786433","display_name":"Tumor microenvironment","level":3,"score":0.4257241487503052},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3700817823410034},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2567763328552246},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.1868659257888794},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18528172373771667},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.18375450372695923},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.14138567447662354},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/2326-6066.c.6551043","doi":"https://doi.org/10.1158/2326-6066.c.6551043","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6551043","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/2326-6066.c.6551043","doi":"https://doi.org/10.1158/2326-6066.c.6551043","is_oa":true,"landing_page_url":"https://doi.org/10.1158/2326-6066.c.6551043","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4297100972","https://openalex.org/W2036018074","https://openalex.org/W148393020","https://openalex.org/W4206077930","https://openalex.org/W2885253947","https://openalex.org/W2133498548","https://openalex.org/W2947747173","https://openalex.org/W4415898572","https://openalex.org/W2496931084","https://openalex.org/W2740653681"],"abstract_inverted_index":{"Abstract":[0],"Cytotoxic":[1],"T":[2],"lymphocytes":[3],"(CTL)":[4],"are":[5],"antigen-specific":[6],"effector":[7,25,91,111],"cells":[8,15],"with":[9,93],"the":[10,23,37,43,62],"ability":[11],"to":[12,51,159],"eradicate":[13],"cancer":[14,33],"in":[16,27,31,71,75,80,148],"a":[17,144],"contact-dependent":[18],"manner.":[19],"Metabolic":[20],"perturbation":[21],"compromises":[22],"CTL":[24,110,138],"response":[26],"tumor":[28,63],"subregions,":[29],"resulting":[30],"failed":[32],"cell":[34,126],"elimination":[35],"despite":[36],"infiltration":[38],"of":[39,45,89,116],"tumor-specific":[40],"CTLs.":[41],"Restoring":[42],"functionality":[44],"these":[46],"tumor-infiltrating":[47],"CTLs":[48,92],"is":[49,56,143],"key":[50],"improve":[52],"immunotherapy.":[53],"Extracellular":[54],"adenosine":[55,85,117,141],"an":[57,155],"immunosuppressive":[58],"metabolite":[59],"produced":[60],"within":[61],"microenvironment.":[64],"Here,":[65],"by":[66,133],"applying":[67],"single-cell":[68],"reporter":[69],"strategies":[70],"3D":[72],"collagen":[73],"cocultures":[74],"vitro":[76],"and":[77,102,113,123,128,137],"progressing":[78],"tumors":[79],"vivo,":[81],"we":[82],"show":[83],"that":[84],"weakens":[86],"one-to-one":[87],"pairing":[88],"activated":[90],"target":[94],"cells,":[95],"thereby":[96],"dampening":[97],"serial":[98],"cytotoxic":[99],"hit":[100,131],"delivery":[101,132],"cumulative":[103],"death":[104],"induction.":[105],"Adenosine":[106],"also":[107],"severely":[108],"compromised":[109],"restimulation":[112],"expansion.":[114],"Antagonization":[115],"A2a":[118],"receptor":[119],"(ADORA2a)":[120],"signaling":[121,142],"stabilized":[122],"prolonged":[124],"CTL\u2013target":[125],"conjugation":[127],"accelerated":[129],"lethal":[130],"both":[134],"individual":[135],"contacts":[136],"swarms.":[139],"Because":[140],"near-constitutive":[145],"confounding":[146],"parameter":[147],"metabolically":[149],"perturbed":[150],"tumors,":[151],"ADORA2a":[152],"targeting":[153],"represents":[154],"orthogonal":[156],"adjuvant":[157],"strategy":[158],"enhance":[160],"immunotherapy":[161],"efficacy.":[162]},"counts_by_year":[],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2023-04-06T00:00:00"}